Pharmaceutical Meets Telehealth: Novo Nordisk and Hims & Hers Settle Patent Dispute with Strategic Alliance

Novo Nordisk A/S and Hims & Hers Health Inc. recently announced a resolution to a patent infringement lawsuit, accompanied by a collaborative agreement that allows Novo Nordisk to sell its GLP-1 medications through the Hims & Hers platform. This decision marks a noteworthy step in the growing intersection of traditional pharmaceuticals and telehealth platforms, as…

Read More

Chicago Trial Against Abbott Examines Health Risks of Cow’s Milk-Based Baby Formula

The ongoing trial in Chicago marks the fourth significant legal confrontation in the United States alleging that cow’s milk-based formulas fed to premature babies pose serious health risks. At the heart of these allegations is the claim that such formulas, when administered in hospital settings, can lead to necrotizing enterocolitis (NEC)—a severe and potentially life-threatening…

Read More

Barnes & Thornburg LLP Expands Public Finance Practice with Key Hires from Ballard Spahr LLP

Barnes & Thornburg LLP has further expanded its public finance practice by welcoming four additional attorneys from Ballard Spahr LLP. This move follows the firm’s recent acquisition of 35 public finance lawyers from Ballard Spahr, which also included the opening of new offices in Baltimore, Denver, and Phoenix. The initial group of 35 attorneys, comprising…

Read More

Law Firms Embrace Client and Practice Diversification for Resilience Amidst Economic Uncertainties

In a shifting legal landscape, many prominent law firms are increasingly prioritizing a balanced portfolio of clients and practices. As firms strive to forge deeper connections with their long-established clients, they are simultaneously seeking diversification in their client bases and practice areas. This dual approach is intended to mitigate risks associated with over-reliance on any…

Read More

Actelion Pharmaceuticals Settles $65 Million Antitrust Case Over Generic Drug Competition

Actelion Pharmaceuticals Ltd. has agreed to a $65 million settlement to address antitrust allegations in a case where the company was accused of blocking generic competition for its hypertension drug, Tracleer. This settlement comes as a resolution to claims made by a certified class, which argued that Actelion unlawfully denied generic drug manufacturers the samples…

Read More

Insurers Win Arbitration Battle, Sidestepping Antitrust Class Action: Implications for Legal and Consumer Landscapes

In a significant development, Judge Brian E. Murphy has granted motions from major insurers, Aetna, Elevance Health, and UnitedHealth, to compel arbitration, effectively allowing them to avoid an antitrust class action. This decision comes amidst ongoing debates over the balance between arbitration and class action lawsuits in addressing alleged anti-competitive practices in the healthcare industry….

Read More

Telehealth Platform Changes Legal Team Amid Novo Nordisk Advertising Dispute

In a significant turn of events, a prominent telehealth platform engaged in a legal battle with pharmaceutical giant Novo Nordisk has switched its legal representation. Novo Nordisk, a major player in the pharmaceutical industry, has accused the telehealth company of misleading advertising concerning alternatives to its GLP-1 drug, Ozempic. The legal proceedings have recently seen…

Read More

State Battles Over Tort Reform Spark National Debate on Legal, Economic Implications

Recent debates in several U.S. states highlight the ongoing struggle over tort reform, an area of significant interest for legal professionals and businesses alike. Key states actively engaging in these discussions include California, Florida, Texas, and Missouri, each grappling with unique aspects of tort reform legislation. In California, a contentious battle looms regarding auto collision…

Read More

Minnesota Sues Trump Administration Over Withholding of $243 Million Medicaid Funds Amid Compliance Dispute

The state of Minnesota has initiated legal action against the Trump administration in response to the withholding of $243 million in Medicaid funding. This move comes amid assertions from the federal administration regarding Minnesota’s “noncompliance” with Medicaid regulations, leading to a threat to cut essential healthcare services for low-income families. Minnesota has filed for a…

Read More

Polsinelli Strengthens Healthcare Legal Expertise with Strategic Hire of Nathaniel Salm

Polsinelli, a prominent Am Law 100 firm, has enhanced its capabilities in the healthcare sector by recruiting experienced attorney Nathaniel Salm to its Fort Lauderdale office. Salm joins the firm from McDermott Will & Emery, where he played a pivotal role in handling complex healthcare transactions and regulatory matters. This strategic acquisition comes as healthcare…

Read More

Appellate Courts to Shape Future of Pharma, Immigration, and Financial Regulation in High-Impact Cases

As legal circles closely follow the latest appellate developments, this month’s action resembles a packed March Madness bracket. The courts face significant cases, each with substantial implications for various sectors, notably Big Pharma, immigration policy, and financial regulation. Major pharmaceutical companies are closely observing proceedings related to the False Claims Act. This legal framework, designed…

Read More

Judge Declines Dismissal in New Directions Patent Case Against Abbott, Signaling Extended Legal Battle

In a recent legal showdown involving New Directions Technology Consulting, a U.S. District Judge delivered a decision that left both litigants with something to contemplate. Judge Richard G. Andrews refused to dismiss New Directions’ patent infringement claims against Abbott Laboratories concerning pacemaker and glucose monitoring technologies. While the decision denied Abbott an easy win, the…

Read More

Delaware Court Case Highlights Tensions Over Intellectual Property in Healthcare Software Industry

In a recent legal battle taking place in Delaware Chancery Court, a developer specializing in software for Medicare treatment has filed a lawsuit against a customer care management firm. The lawsuit alleges that this company illicitly leveraged the developer’s platform to craft a competing application. The legal action underscores the tension that can arise when…

Read More

Gordon Rees Scully Mansukhani Expands National Reach with New Offices in Charlotte and Madison

In a strategic expansion of its national footprint, Gordon Rees Scully Mansukhani has recently launched new offices in Charlotte, North Carolina, and Madison, Wisconsin. This move aims to bolster the firm’s legal services in key regions of the Southeast and Midwest. The firm, renowned for its full-service capabilities, continues its growth trajectory by penetrating these…

Read More

Oregon Jury Awards Historic $242 Million in Wildfire Liability Verdict, Signaling Shift in Mass Litigation Outlook

An Oregon jury has delivered a significant verdict, awarding a record $242 million in a wildfire lawsuit. This outcome is poised to have substantial implications for future litigation involving natural disasters and liability. The case revolved around the determination of fault concerning a devastating wildfire that ravaged vast swathes of Oregon countryside, causing extensive damage…

Read More

Moderna to Pay $950 Million in Settlement Over COVID-19 Vaccine Patent Dispute

In a significant resolution to a prolonged legal dispute, Moderna has agreed to pay $950 million to address global patent litigation concerning its COVID-19 vaccines. This settlement involves claims made by Arbutus Biopharma Corp. and its partner, Genevant Sciences. The agreement not only resolves ongoing litigation but also eliminates the potential for future royalties as…

Read More

Federal Circuit’s Ruling Reshapes Patent Challenge Dynamics in Augmented Reality Surgical Innovations

The Federal Circuit has issued a significant decision, reviving part of a patent challenge related to augmented reality (AR) in surgical applications. On Tuesday, the court overturned a previous ruling by the Patent Trial and Appeal Board (PTAB), which had dismissed the objections made by a medical technology firm. The Federal Circuit determined that there…

Read More

Winston & Strawn Enhances Antitrust Expertise with DOJ Attorney Hire Amid Intensified Regulatory Scrutiny

Winston & Strawn LLP has expanded its antitrust capabilities by bringing in a seasoned trial attorney from the U.S. Department of Justice’s Antitrust Division. This move comes as the firm enhances its strategic positioning within Washington, D.C.’s highly competitive legal market. The new addition to Winston & Strawn’s team, who was involved in the high-profile…

Read More

King & Spalding Enhances Dallas Office with Key Hires from Winston & Strawn Amid Texas Market Growth

King & Spalding LLP, a leading international law firm, announced the expansion of its Dallas office with the addition of three prominent attorneys from Winston & Strawn LLP. The move, revealed on Tuesday, signals King & Spalding’s ongoing commitment to bolstering its presence in the competitive Texas legal market. This strategic enhancement is seen as…

Read More

Federal Judge’s Ruling Allows Northwestern Hospital to Seek Equitable Relief in BCBS Dispute

In a recent decision, a federal judge has ruled that Northwestern Hospital is permitted to pursue equitable relief in its dispute with Blue Cross Blue Shield Illinois (BCBS). This ruling reflects an ongoing division among courts within the district regarding the viability of quantum meruit claims against third-party beneficiaries involved in BCBS Illinois contracts. The…

Read More

King & Spalding Strengthens Dallas Presence Through Strategic Partner Hires from Winston & Strawn

In a strategic move to bolster its capabilities in the Dallas metropolitan area, King & Spalding has successfully recruited additional partners from Winston & Strawn. This marks a continued expansion effort by King & Spalding, which has been steadily increasing its presence in Texas’ competitive legal market. The firm has brought over several notable figures…

Read More

Australia’s Offshore Asylum Program Under Scrutiny: Human Rights Concerns and Financial Implications

The recent evaluation of Australia’s offshore processing and resettlement program by Human Rights Watch (HRW) has raised significant concerns about its efficiency and compliance with international law. In a detailed submission to the Australian Senate’s Legal and Constitutional Affairs References Committee, HRW outlined that the program is a stark example of externalization, a strategy employed…

Read More

FDA’s New Biosimilarity Guidance Aims to Revolutionize Biologic Drug Market Access

The closing of the public comment period on January 20 for the U.S. Food and Drug Administration’s draft guidance on demonstrating biosimilarity marks a pivotal moment in the regulation of biosimilars. Released on October 29, 2025, the guidance outlines significant updates aimed at simplifying biosimilarity studies. These changes are intended to ease the pathway for…

Read More